Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial

By Tolosa Eduardo   Hernández Basilio   Linazasoro Gurutz   López-Lozano Juan   Mir Pablo   Marey José   Kulisevsky Jaime  

Journal of Neural Transmission, Vol. 121, Iss. 4, 2014-04 ,pp. : 357-366

Springer Publishing Company

Access to resources Recommend Favorite

Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson’s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study

By Onofrj M.   Thomas A.   Vingerhoets F.   Martin W.   Giménez-Roldán S.   Azulay J.-P.   Bernhard G.   Schmidt W.   Markabi S.  

Journal of Neural Transmission, Vol. 111, Iss. 8, 2004-08 ,pp. : 1053-1063

Springer Publishing Company

Access to resources Recommend Favorite

Effect of MTHFR Polymorphisms on Hyperhomocysteinemia in Levodopa-treated Parkinsonian Patients

By Caccamo D.  

NeuroMolecular Medicine, Vol. 9, Iss. 3, 2007-09 ,pp. : 249-254

Humana Press, Inc

Access to resources Recommend Favorite

Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation

By Moro E.   Esselink R.J.A.   Benabid A.L.   Pollak P.  

Brain, Vol. 125, Iss. 11, 2002-11 ,pp. : 2408-2417

Oxford University Press

Access to resources Recommend Favorite

Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson’s disease

By Müller T.   Erdmann C.   Muhlack S.   Bremen D.   Przuntek H.   Goetze O.   Woitalla D.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1441-1448

Springer Publishing Company

Access to resources Recommend Favorite